Risk of litigation arising from adverse effects, quality issues and partnership disputes
First written in FY2016. 17 of 18 entries say "Restated". Latest entry: FY2023-Q3.
No other company in this theme has enough history to compare yet.
- FY2023-Q3RestatedAnnual report
「During the nine months ended the third quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2023-Q2RestatedAnnual report
「During the six months ended the second quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2023-Q1RestatedAnnual report
「During the three months ended the first quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2022-Q3RestatedAnnual report
「During the nine months ended the third quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2022-Q2RestatedAnnual report
「During the six months ended the second quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2022-Q1RestatedAnnual report
「During the three months ended the first quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2020-Q3RestatedAnnual report
「During the nine months ended the third quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2020-Q2RestatedAnnual report
「During the six months ended the second quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2019RestatedAnnual report
「The Company cannot rule out the possibility of facing unexpected health hazards arising from adverse effects or quality-control issues. Nor can it rule out the possibility of disputes with counterparties concerning the content and terms of partnerships or whether partnership relationships should continue.」
The risk of adverse effects, quality issues and partnership disputes developing into litigation continues to be disclosed. - FY2019-Q3RestatedAnnual report
「During the nine months ended the third quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2019-Q2RestatedAnnual report
「During the six months ended the second quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2019-Q1RestatedAnnual report
「During the three months ended the first quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2018-Q2RestatedAnnual report
「During the six months ended the second quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2017RestatedAnnual report
「The Company cannot rule out the possibility of facing unexpected health hazards arising from adverse effects or quality-control issues. Nor can it rule out the possibility of disputes with counterparties concerning the content and terms of partnerships or whether partnership relationships should continue.」
The risk of litigation arising from adverse effects, quality issues and partnership disputes continues to be disclosed. - FY2017-Q3RestatedAnnual report
「During the nine months ended the third quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2017-Q2RestatedAnnual report
「During the six months ended the second quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2017-Q1RestatedAnnual report
「During the three months ended the first quarter of the current fiscal year, there were no new occurrences or material changes in the principal risks likely to affect the business results or financial condition of the Group.」
It has been explained that there have been no new occurrences or material changes in the risk of litigation arising from adverse effects, quality issues and partnership disputes. - FY2016First statedAnnual report
「The Company cannot rule out the possibility of facing unexpected health hazards arising from adverse effects or quality-control issues. Nor can it rule out the possibility of disputes with counterparties concerning the content and terms of partnerships or whether partnership relationships should continue.」
The impact on business performance and financial position if these matters develop into litigation is explained.